sb 203580 has been researched along with eicosapentaenoic acid in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (eicosapentaenoic acid) | Trials (eicosapentaenoic acid) | Recent Studies (post-2010) (eicosapentaenoic acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 7,171 | 1,304 | 3,623 |
| Protein | Taxonomy | sb 203580 (IC50) | eicosapentaenoic acid (IC50) |
|---|---|---|---|
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 7.1 | |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awazu, M; Fujita, H; Hida, M; Hoshiya, M; Ishikura, K; Omori, S | 1 |
1 other study(ies) available for sb 203580 and eicosapentaenoic acid
| Article | Year |
|---|---|
Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-beta in mesangial cells.
Topics: Animals; Antibodies; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Eicosapentaenoic Acid; Enzyme Activation; Enzyme Inhibitors; Glomerular Mesangium; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Mitosis; Phosphorylation; Platelet-Derived Growth Factor; Proto-Oncogene Proteins; Pyridines; Rats; Receptors, Platelet-Derived Growth Factor; Thymidine; Transforming Growth Factor beta | 2003 |